loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2000_270___rev_04 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Krka

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 KRKA, d.d., Novo mesto Novo mesto SI (1)

    filter

    01 Norfloxacin (1)

    filter

    01 Slovenia (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    KRKA, d.d., Novo mesto Novo mesto S...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Slovenia
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Norfloxacin

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2000-270 - Rev 04
    Withdrawn by Holder
    Chemical
    2013-03-14
    2021-01-26
    1248
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-270 - Rev 04 of Krka, D.d., Novo Mesto Novo Mesto Si

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2000-270 - Rev 04 of Krka, D.d., Novo Mesto Novo Mesto Si 1

    20

    Krka, D.d., Novo Mesto Novo Mesto Si, based in Slovenia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their significant offerings is Norfloxacin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2000-270 - Rev 04

    This Chemical Type CEP, issued on March 14, 2013, remains in force until January 26, 2021, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1248 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY